SuperGen, Inc. To Present At The Ninth Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
DUBLIN, Calif., Feb. 5 /PRNewswire-FirstCall/ -- SuperGen Inc. today announced that Dr. James S. Manuso, President and CEO, will present a corporate overview and highlight SuperGen's recent developments at the BIO CEO & Investor Conference at 11:45 a.m. EST on Monday, Feb. 12, 2007, at the Waldorf Astoria Hotel in New York City.
A live Webcast of Dr. Manuso's presentation will be available on the Investor Relations section of the company's Web site at www.supergen.com. The Webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen is a pharmaceutical company dedicated to the discovery, acquisition, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on inhibitors of aurora-A, tyrosine kinase and DNA methyltransferase. For more information about SuperGen, please visit http://www.supergen.com.
Contacts: SuperGen Noonan Russo Timothy L. Enns Greg Geissman S.V.P., Corporate Communications Director of Media Relations & Business Development (858) 646-3058 (925) 560-0100 x111 greg.geissman@eurorscg.comtenns@supergen.com
SuperGen Inc.CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & BusinessDevelopment of SuperGen, +1-925-560-0100 x111, or tenns@supergen.com; orGreg Geissman, Director of Media Relations of Noonan Russo for SuperGen,+1-858-646-3058, greg.geissman@eurorscg.com
Web site: http://www.supergen.com/